BiotechTube
Home/NaDeNo/Annbjørg Falck
AF

Annbjørg Falck

Chief Executive Officer and Co-founder

NaDeNo

Therapeutic Areas

Oncology

NaDeNo Pipeline

DrugIndicationPhase
PACAB-002Peritoneal micrometastases in High-Grade Serous Ovarian CancerPre-clinical

Leadership Team at NaDeNo

ÝM
Ýrr Mørch
Chief Technology Officer and Co-founder
View full NaDeNo profile